Cargando…
Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes
To maintain normal glucose homeostasis after a meal, it is essential to secrete an adequate amount of insulin from pancreatic β-cells. However, if pancreatic β-cells solely depended on the blood glucose level for insulin secretion, a surge in blood glucose levels would be inevitable after the ingest...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Endocrine Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008660/ https://www.ncbi.nlm.nih.gov/pubmed/36781163 http://dx.doi.org/10.3803/EnM.2023.103 |
_version_ | 1784905805481377792 |
---|---|
author | Ahn, Chang Ho Oh, Tae Jung Min, Se Hee Cho, Young Min |
author_facet | Ahn, Chang Ho Oh, Tae Jung Min, Se Hee Cho, Young Min |
author_sort | Ahn, Chang Ho |
collection | PubMed |
description | To maintain normal glucose homeostasis after a meal, it is essential to secrete an adequate amount of insulin from pancreatic β-cells. However, if pancreatic β-cells solely depended on the blood glucose level for insulin secretion, a surge in blood glucose levels would be inevitable after the ingestion of a large amount of carbohydrates. To avoid a deluge of glucose in the bloodstream after a large carbohydrate- rich meal, enteroendocrine cells detect the amount of nutrient absorption from the gut lumen and secrete incretin hormones at scale. Since insulin secretion in response to incretin hormones occurs only in a hyperglycemic milieu, pancreatic β-cells can secrete a “Goldilocks” amount of insulin (i.e., not too much and not too little) to keep the blood glucose level in the normal range. In this regard, pancreatic β-cell sensitivity to glucose and incretin hormones is crucial for maintaining normal glucose homeostasis. In this Namgok lecture 2022, we review the effects of current anti-diabetic medications on pancreatic β-cell sensitivity to glucose and incretin hormones. |
format | Online Article Text |
id | pubmed-10008660 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Korean Endocrine Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-100086602023-03-13 Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes Ahn, Chang Ho Oh, Tae Jung Min, Se Hee Cho, Young Min Endocrinol Metab (Seoul) Namgok Lecture 2022 To maintain normal glucose homeostasis after a meal, it is essential to secrete an adequate amount of insulin from pancreatic β-cells. However, if pancreatic β-cells solely depended on the blood glucose level for insulin secretion, a surge in blood glucose levels would be inevitable after the ingestion of a large amount of carbohydrates. To avoid a deluge of glucose in the bloodstream after a large carbohydrate- rich meal, enteroendocrine cells detect the amount of nutrient absorption from the gut lumen and secrete incretin hormones at scale. Since insulin secretion in response to incretin hormones occurs only in a hyperglycemic milieu, pancreatic β-cells can secrete a “Goldilocks” amount of insulin (i.e., not too much and not too little) to keep the blood glucose level in the normal range. In this regard, pancreatic β-cell sensitivity to glucose and incretin hormones is crucial for maintaining normal glucose homeostasis. In this Namgok lecture 2022, we review the effects of current anti-diabetic medications on pancreatic β-cell sensitivity to glucose and incretin hormones. Korean Endocrine Society 2023-02 2023-02-13 /pmc/articles/PMC10008660/ /pubmed/36781163 http://dx.doi.org/10.3803/EnM.2023.103 Text en Copyright © 2023 Korean Endocrine Society https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Namgok Lecture 2022 Ahn, Chang Ho Oh, Tae Jung Min, Se Hee Cho, Young Min Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes |
title | Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes |
title_full | Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes |
title_fullStr | Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes |
title_full_unstemmed | Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes |
title_short | Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes |
title_sort | incretin and pancreatic β-cell function in patients with type 2 diabetes |
topic | Namgok Lecture 2022 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008660/ https://www.ncbi.nlm.nih.gov/pubmed/36781163 http://dx.doi.org/10.3803/EnM.2023.103 |
work_keys_str_mv | AT ahnchangho incretinandpancreaticbcellfunctioninpatientswithtype2diabetes AT ohtaejung incretinandpancreaticbcellfunctioninpatientswithtype2diabetes AT minsehee incretinandpancreaticbcellfunctioninpatientswithtype2diabetes AT choyoungmin incretinandpancreaticbcellfunctioninpatientswithtype2diabetes |